Prediagnostic serum organochlorine insecticide concentrations and primary liver cancer: A case-control study nested within two prospective cohorts.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 12 07 2018
revised: 30 11 2018
accepted: 10 01 2019
pubmed: 1 2 2019
medline: 24 1 2020
entrez: 1 2 2019
Statut: ppublish

Résumé

Although experimental evidence indicates that certain organochlorine insecticides are hepatocarcinogens, epidemiologic evidence for most of these chemicals is very limited. We estimated associations, using prospectively collected sera, between organochlorine insecticide concentrations and cancer registry-identified primary liver cancer in two cohorts, one from the United States and one from Norway. In nested case-control studies, we used sera collected in the 1960s-1980s from 136 cases and 408 matched controls from the Kaiser Permanente Northern California Multiphasic Health Checkup (MHC) cohort and 84 cases and 252 matched controls from the population-based Norwegian Janus cohort. We measured concentrations of nine organochlorine insecticides/metabolites and markers of hepatitis B and C in sera. Adjusted odds ratios (OR) and 95% confidence intervals (CI) for tertiles of lipid-corrected organochlorines were calculated for each cohort using conditional logistic regression. Among MHC participants with sera from the 1960s, there was a suggestive exposure-response trend for trans-nonachlor (second and third tertile of analyte ORs = 1.63 and 1.95, respectively; p-trend = 0.08) and a nonsignificantly elevated risk for the highest tertile of oxychlordane (OR = 1.87). Among Janus participants with sera from the 1970s, we observed an apparent trend for p,p'-DDT (second and third tertile ORs = 1.70 and 2.14, respectively; p-trend = 0.15). We observed little consistency in patterns of association between the cohorts. We found limited evidence that exposure to p,p'-DDT and chlordane-related oxychlordane and trans-nonachlor may be associated with increased risk of primary liver cancer. However, the modest strength of these associations and their lack of concordance between cohorts necessitate caution in their interpretation.

Identifiants

pubmed: 30701531
doi: 10.1002/ijc.32175
pmc: PMC6667305
mid: NIHMS1017828
doi:

Substances chimiques

Hydrocarbons, Chlorinated 0
Insecticides 0
Chlordan 12789-03-6
oxychlordane 27304-13-8
DDT CIW5S16655

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2360-2371

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA197402
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES014662
Pays : United States

Informations de copyright

© 2019 UICC.

Références

Hum Exp Toxicol. 2004 Oct;23(10):463-71
pubmed: 15553171
Arch Environ Contam Toxicol. 1989 Jul-Aug;18(4):495-500
pubmed: 2505694
Int J Epidemiol. 2017 Aug 1;46(4):1101-1102f
pubmed: 28087783
Environ Health Perspect. 2010 Jun;118(6):796-802
pubmed: 20146964
Am J Gastroenterol. 2013 Aug;108(8):1314-21
pubmed: 23752878
Int J Cancer. 1993 Sep 9;55(2):196-201
pubmed: 7690345
BMC Med Res Methodol. 2014 Dec 22;14:137
pubmed: 25532820
Arch Intern Med. 1969 Jun;123(6):664-81
pubmed: 5771054
Environ Health Perspect. 2004 Jul;112(10):1080-4
pubmed: 15238281
Int J Epidemiol. 1993 Aug;22(4):674-6
pubmed: 8225742
Arch Toxicol. 2017 Jan;91(1):83-96
pubmed: 27438348
J Expo Sci Environ Epidemiol. 2012 Nov;22(6):541-8
pubmed: 21915153
Int J Cancer. 2007 Feb 1;120(3):642-9
pubmed: 17096337
Prev Med. 1973 Jun;2(2):197-206
pubmed: 4723635
Cancer. 2016 Jun 1;122(11):1757-65
pubmed: 26998818
Scand J Infect Dis. 2000;32(3):249-52
pubmed: 10879593
Bull Environ Contam Toxicol. 1987 Nov;39(5):827-34
pubmed: 3690008
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):16-27
pubmed: 26667886
Am J Public Health. 1992 May;82(5):703-10
pubmed: 1566949
Gastroenterology. 2012 May;142(6):1264-1273.e1
pubmed: 22537432
Toxicol Ind Health. 2002 Mar;18(2):63-70
pubmed: 12868794
Toxicol Sci. 2016 Mar;150(1):169-77
pubmed: 26748080
J Natl Cancer Inst. 2006 Jul 19;98(14):1005-10
pubmed: 16849683
Environ Health Perspect. 1993 Dec;101 Suppl 5:219-23
pubmed: 8013410
Environ Int. 2011 Oct;37(7):1226-35
pubmed: 21683445
Environ Res. 2015 Nov;143(Pt A):68-82
pubmed: 26451881
Cancer Res. 2005 Oct 15;65(20):9588-94
pubmed: 16230425
Sci Rep. 2016 May 17;6:25768
pubmed: 27185567
Epidemiology. 2005 Jul;16(4):516-25
pubmed: 15951670
Kidney Int. 1982 Jul;22(1):63-8
pubmed: 6181284
Environ Health Perspect. 2001 Feb;109(2):173-8
pubmed: 11266329
Sci Total Environ. 2005 Apr 15;342(1-3):87-106
pubmed: 15866269
Gastroenterology. 2002 Dec;123(6):2082-99
pubmed: 12454863
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Lancet Oncol. 2015 Aug;16(8):891-2
pubmed: 26111929
Scand J Work Environ Health. 1992 Jun;18(3):155-61
pubmed: 1615289
Environ Health Perspect. 2000 Mar;108(3):205-11
pubmed: 10706525
Int J Cancer. 2012 Nov 1;131(9):2078-84
pubmed: 22290210
Environ Health. 2017 Sep 6;16(1):95
pubmed: 28874165
Int J Epidemiol. 2017 Apr 1;46(2):403-404g
pubmed: 27063606
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Aug 25;794(1):137-48
pubmed: 12888206
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487

Auteurs

Lawrence S Engel (LS)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC.

Emily C Zabor (EC)

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY.

Jaya Satagopan (J)

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY.

Anders Widell (A)

Department of Medical Microbiology, Lund University, Malmö, Sweden.

Nathaniel Rothman (N)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD.

Thomas R O'Brien (TR)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD.

Mingdong Zhang (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD.

Stephen K Van Den Eeden (SK)

Division of Research, Kaiser Permanente Northern California, Oakland, CA.

Tom K Grimsrud (TK)

Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH